Biotech Values

[DewDiligence]

SLXP +6% on plan to accelerate inventory drawdown:

http://www.wsj.com/articles/salix-pharmaceuticals-to-clear-wholesaler-inventory-withdraws-guidance-1418733547

“The board and management have determined that the decision to accelerate the reduction of wholesale inventory levels, which reflects the views expressed by our largest shareholders, best positions Salix for future success,” the company said in a release Tuesday.

Salix said it plans to sell minimal amounts of its top-selling product Xifaxan, as well as Apriso and Uceris, to its wholesalers in the current quarter to meet its goal of reducing inventory levels to three months by the end of 2015—one year earlier than previously announced.

Sounds like BS to me. If this is a good idea, why did management need to be told to do it?